Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

PureTech (PRTC) Share Price

Price 107.80p on 02-10-2026 at 18:25:11
Change -2.80p -2.53%
Buy 108.60p
Sell 108.20p
Last Trade: Sell 33,180.00 at 107.80p
Day's Volume: 856,820
Last Close: 107.80p
Open: 110.80p
ISIN: GB00BY2Z0H74
Day's Range 107.20p - 110.80p
52wk Range: 107.20p - 142.00p
Market Capitalisation: £264.30m
VWAP: 108.47908p
Shares in Issue: 245.18m

PureTech (PRTC) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 33,180 107.80p Ordinary
16:37:51 - 02-Oct-26
Sell* 137,990 107.80p Uncrossing Trade
16:35:04 - 02-Oct-26
Buy* 592 108.60p SI Trade
16:28:42 - 02-Oct-26
Sell* 675 108.20p Automatic Execution
16:28:42 - 02-Oct-26
Sell* 544 108.20p Automatic Execution
16:28:42 - 02-Oct-26
Buy* 504 108.60p Automatic Execution
16:28:41 - 02-Oct-26
Buy* 641 108.60p Automatic Execution
16:28:41 - 02-Oct-26
Buy* 199 108.60p Automatic Execution
16:28:41 - 02-Oct-26
Sell* 1,444 108.40p Automatic Execution
16:28:41 - 02-Oct-26
Sell* 383 108.40p Automatic Execution
16:28:41 - 02-Oct-26
See more PureTech trades

PureTech (PRTC) Share Price History

Time period:
to
Date Open High Low Close Volume
2nd Oct 2026 (Fri) 110.80 110.80 107.20 107.80 856,820
1st Oct 2026 (Thu) 115.60 115.60 110.60 110.60 411,797
30th Sep 2026 (Wed) 114.20 115.40 114.20 115.00 758,816
29th Sep 2026 (Tue) 115.00 117.60 114.20 114.20 282,712
28th Sep 2026 (Mon) 115.40 118.20 115.20 115.60 740,393
25th Sep 2026 (Fri) 116.20 117.00 114.40 114.40 651,606
24th Sep 2026 (Thu) 113.00 117.40 113.00 116.00 332,768
23rd Sep 2026 (Wed) 112.20 116.00 110.40 116.00 1,435,329
22nd Sep 2026 (Tue) 124.00 126.80 111.80 112.20 2,308,991
21st Sep 2026 (Mon) 122.80 122.80 121.00 121.00 307,451
18th Sep 2026 (Fri) 124.60 126.00 122.00 122.60 766,489
17th Sep 2026 (Thu) 124.00 124.00 120.20 123.60 254,803
16th Sep 2026 (Wed) 118.00 120.20 118.00 119.40 230,347
15th Sep 2026 (Tue) 120.80 120.80 119.80 119.80 403,409
14th Sep 2026 (Mon) 118.00 120.60 118.00 119.40 741,574
11th Sep 2026 (Fri) 120.60 122.40 119.40 119.40 268,224
10th Sep 2026 (Thu) 120.00 121.80 118.40 120.60 842,178
9th Sep 2026 (Wed) 123.00 123.00 119.80 120.80 446,134
8th Sep 2026 (Tue) 118.00 121.40 118.00 121.40 538,419
7th Sep 2026 (Mon) 123.00 123.00 120.00 120.60 265,671
4th Sep 2026 (Fri) 126.00 126.00 119.80 121.60 837,625
3rd Sep 2026 (Thu) 125.00 127.00 121.00 126.00 1,591,337
See more PureTech price history

PureTech (PRTC) Regulatory News

Date Source Headline
25th Sep 2026 6:13 pm RNS Holding(s) in Company
22nd Sep 2026 7:00 am RNS Half-year Report
21st Sep 2026 7:00 am RNS-R PRTC's Gallop: Positive FDA Meeting & Fast Track
18th Sep 2026 5:00 pm RNS Holding(s) in Company
9th Sep 2026 6:00 pm RNS-R PRTC's SPTX: New Positive Phase 1 GlyphAllo Data
4th Sep 2026 5:30 pm RNS Holding(s) in Company
4th Sep 2026 7:00 am RNS Notice of Results
1st Sep 2026 7:00 am RNS Total Voting Rights
28th Aug 2026 7:00 am RNS Holding(s) in Company
25th Aug 2026 12:05 pm RNS-R PRTC's Celea:2 Deupirfenidone Presentations at ERS
See more PureTech regulatory news

PureTech (PRTC) Share News

PureTech swings to first-half profit as investment gains soar

22nd Sep 2026 12:42

(Alliance News) - PureTech PLC on Tuesday hailed "significant progress" across its portfolio as it swung to a first-half profit. Read More

PureTech Health says US FDA progress provides clear path for LYT-200

21st Sep 2026 10:34

(Alliance News) - PureTech Health PLC on Monday said feedback from the US Food & Drug Administration supports the advancement of its blood cancer treatment, LYT-200. Read More

UK earnings, trading statements calendar - next 7 days

15th Sep 2026 14:30

Read More

EARNINGS AND TRADING: Pebble Beach revenue grows as forecast

9th Sep 2026 19:21

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

PureTech Health announces first patient dosing in Celea phase 3 trial

13th Jul 2026 10:17

(Alliance News) - PureTech Health PLC on Monday said its founded entity Celea Therapeutics has announced the first dosing in a phase 3 trial. Read More

See more PureTech news
FTSE 100 Latest
Value10,461.95
Change33.68

Login to your account

Forgot Password?

Not Registered